IHU Méditerranée Infection

What IHU Méditerranée Infection does

IHU Méditerranée Infection is a French university-hospital institute (Institut Hospitalo-Universitaire) headquartered at 19-21 Boulevard Jean Moulin, 13005 Marseille, operating as the Fondation Méditerranée Infection under French foundation law (SIRET 50198088200028). It integrates infectious and tropical disease clinical care, advanced diagnostics, basic and applied research, and higher education within a single purpose-built facility. It serves three primary constituencies: patients requiring specialist infectious and tropical disease care, French public health authorities through three designated National Reference Centers (Rickettsioses, ArboVIRUS, Malaria), and an international research community with formal partnerships spanning Senegal, Vietnam, Cameroon, and Algeria through the Infectiopole Sud network. Pierre-Edouard Fournier serves as the foundation's legal representative.

The institute operates ten specialized technology platforms: next-generation sequencing (NGS), proteomics via MALDI-TOF, culturomics, scanning and transmission electron microscopy, a BSL-3 containment laboratory, biobank, microbial strain collection, insectarium, and veterinary research center. Four research units (MEPHI, RITMES, SESSTIM, UVE) and a portfolio of proprietary bioinformatics databases (URMS, ARG-ANNOT, Beta-lactamase Database, NRPPUR, BUR, OXYTOL, SVARAP/aSVARAP, MG-Digger) underpin core capabilities. Service lines include hospitalization, outpatient consultations, travel medicine and vaccination, diagnostic laboratory testing, epidemiological surveillance, and academic programs spanning Master's through Post-Doctorate, plus 890+ educational videos on YouTube.

The business model is fundamentally public-sector and grant-funded. Clinical services are reimbursed through the French Sécurité Sociale via AP-HM and CHU Timone; research and platform investments are financed through the France 2030 program, ANR competitive grants, the Investir L'Avenir initiative, and Aix-Marseille Université. Commercial activity is nascent and emerging: startup incubation services launched in 2025, the EMERGENCES international congress scheduled for 2027, and the HITACHI educational partnership extend the institute's reach beyond its traditional public funding base. Revenue figures are not publicly disclosed.

Name

IHU Méditerranée Infection

Legal name

Fondation Méditerranée Infection

Website

https://mediterranee-infection.com

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

IHU Méditerranée Infection is a French university-hospital institute in Marseille that delivers integrated infectious disease clinical care, advanced diagnostics, and research through ten technology platforms, four research units, and three National Reference Centers, serving French public health authorities and international partners.

Ownership category

akta.pro rank

Product category

Infectious Disease Research and Clinical Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Offices of Physicians (62111), Ambulatory Health Care Services (621)

SIC

Services-Medical Laboratories (8071), Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Inpatient Infectious Disease & Isolation Specialty Hospitals (HLAFAHAI)

akta.pro secondary industries

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI), National Public Health Reference Laboratories (HLAJAIAA), Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza) (HLAJAIAD), General Infectious Disease (HLAKAGAA), Public Health Laboratories & Diagnostic Oversight (BPAIAJAF), Laboratory Informatics & Reporting (LIMS/ELR) Public Health Networks (HLAJAIAN)

Keywords

• Infectious disease research
• Clinical microbiology services
• Tropical medicine care
• Genomic pathogen analysis
• Public health surveillance

Headquarters

HQ city

Marseille-en-beauvaisis

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Distribution channels3 records

Marketing channels6 records

Core offering

IHU Méditerranée Infection is a French university hospital institute that delivers integrated infectious disease clinical care, advanced laboratory diagnostics, and scientific research from a single purpose-built facility in Marseille. The institute operates three National Reference Centers (Rickettsioses, ArboVIRUS, Malaria) and provides specialized reference diagnostic services to healthcare facilities across France. It also runs university education programs (Masters, Doctorate, Post-Doctorate), continuing education, and startup incubation services in the infectious disease domain.

Product overview

IHU Méditerranée Infection is a French university hospital institute (Institut Hospitalo-Universitaire) specializing in infectious and tropical diseases. Based in Marseille, it operates as an integrated research center combining clinical care, advanced laboratory diagnostics, and scientific research. The institute offers a comprehensive portfolio organized around four pillars: Soins (clinical care including hospitalization, consultations, vaccination, and day hospital services), Diagnostic (laboratory services including National Reference Centers for Rickettsioses, arboVIRUS, Malaria, and vector-borne diseases), Rechercher (research through units MEPHI, RITMES, SESSTIM, and UVE), and Innover (innovation platforms and incubation services). The institute maintains extensive technological platforms including next-generation sequencing (NGS), proteomics, culturomics, electron microscopy (scanning and transmission), biobanking, strain collections, serology, lyophilization, BSL3 laboratory, insectarium, and veterinary research center. Additionally, it provides public bioinformatics databases and tools including ARG-ANNOT, SVARAP/aSVARAP, Beta-lactamase Database, NRPPUR, Bacteriocins Database, URMS mass spectrometry reference, and Multi Spacers Typing (MST) for the scientific community.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Care Services (Soins)

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Partnerships

Five partnerships are on record, tiered core, regional and minor.

• Aix-Marseille Université (AMU)coreStrategic or Co-development PartnerPrimary academic partner providing the university framework for research and education activities. The institute is integrated with AMU's Faculty of Medicine, enabling academic programs from Masters through Post-Doctorate levels.
• Assistance Publique - Hôpitaux de Marseille (AP-HM)coreStrategic or Co-development PartnerParent public hospital system providing the clinical care infrastructure and patient access. AP-HM operates the hospital facilities within which the IHU delivers clinical services.
• CHU TimonecoreStrategic or Co-development PartnerTeaching hospital within AP-HM serving as the primary clinical facility for the institute's infectious disease care and teaching activities.
• Infectiopole SudregionalStrategic or Co-development PartnerSouthern France infectious disease network coordinating regional expertise in infectious diseases across the Provence-Alpes-Côte d'Azur and neighboring regions.
• HITACHI Educational ProgramminorStrategic or Co-development PartnerEducational partnership program for specialized training in infectious diseases. The specific nature of the HITACHI partnership relates to educational content and training delivery.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Others

• Assistance Publique – Hôpitaux de Marseille (AP-HM): Parent public hospital system hosting IHU's clinical activities and CHU Timone. Not a peer competitively but the structural host partner whose clinical infrastructure underwrites IHU's inpatient and ambulatory services.

Direct peers

• Swiss Tropical and Public Health Institute: Swiss institute associated with the University of Basel combining tropical medicine research, public health, and diagnostic reference work. Comparable scope in tropical/infectious disease research and international collaboration.
• Fondation Mérieux: French family foundation focused on fighting infectious diseases in developing countries through laboratory capacity building, diagnostics access, and applied research. Closely matches IHU's foundation structure and Global South orientation.
• Bernhard Nocht Institute for Tropical Medicine: Germany's reference center for tropical and infectious diseases, combining clinical care, reference diagnostics, and high-containment research. Mirrors IHU's integrated tropical medicine + reference laboratory + research model at European scale.
• Institut Pasteur: France's flagship private foundation for infectious disease research, clinical reference, and teaching. Comparable as a multi-center French infectious disease institute with CNR-equivalent functions, BSL infrastructure, and a global research footprint.
• Institut de Recherche pour le Développement (IRD): French public research organization with strong tropical and infectious disease programs across the Global South. Comparable partner profile, particularly given IHU's stated south-oriented international collaborations.

Broad incumbents

• London School of Hygiene & Tropical Medicine: Larger and longer-established European institution focused on infectious disease and public health research and education. Overlaps with IHU's research and teaching missions, particularly around tropical medicine and outbreak epidemiology.
• Wellcome Sanger Institute: Large UK genomics institute with major infectious disease surveillance and pathogen genomics programs (e.g., COVID-19 Genomics UK Consortium). Comparable on the genomics and bioinformatics database side of IHU's platform stack.
• National Institute of Allergy and Infectious Diseases (NIAID): US federal institute funding and conducting infectious and immune-mediated disease research globally. Much larger in scale but the closest analogue for an integrated research/reference/clinical infectious disease mission.

Emerging players

• Centre for Infectious Disease Research in Zambia (CIDRZ): African infectious disease research and implementation organization partnering with European reference institutes. Comparable as a Global South counterpart collaborating on tropical disease surveillance and laboratory capacity building.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@ihu_medinfection
• LinkedInlinkedin.com/company/mediterranee-infection
• Xx.com/IHU_Marseille
• Facebookfacebook.com/medInfection

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IHU Méditerranée Infection